Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Association of British Pharmaceutical Industry

An important feature of the code is its universal applicability. All companies that are members of an affiliated trade association (e.g. ABPI [Association of British Pharmaceutical Industries], LEEM [Les enterprises du medicament or French Pharmaceutical Companies Association], LIF [Swedish Association of the Pharmaceutical Industry], Interpharma) are required to apply the minimum standards of the code wherever they do business. Companies entering into licensing and agency agreements are expected to require their licensees and agents to respect the provisions of the IFPMA code. [Pg.18]

The Association of British Pharmaceutical Industry. Code of Practice, 2006 (www.abpi.org.uk/publications/pdfs/pmpca code2006.pdf). [Pg.210]

The Committee had no legal powers, but worked with the voluntary agreement of the Association of British Pharmaceutical Industry and the Proprietary Association of Great Britain. They promised that none of their members would put on clinical trial or release for marketing a new drug against the advice of the Committee, whose advice they would always seek. [Pg.425]

Association of British Pharmaceutical Industry, World Review. [Pg.920]

It should be noted that the guidelines issued by the (UK) Pharmaceutical Society and the Association of British Pharmaceutical Industries (ABPI) on OPD indicate that packs should be both tamper-evident and child-resistant. [Pg.440]

In addition to the provisions of the UK Medicines Act (1962) and European Directives, and other similar mandates, the pharmaceutical industry also carries out a measure of self-regulation through its own industry bodies. For example, in the UK, the Association of British Pharmaceutical Industries (ABPI) operates codes of practice concerning, for example, the promotion of prescription only and OTC products. [Pg.418]

Association of British Pharmaceutical Industries, Annual Report, 1983-84. [Pg.227]

The Association of British Pharmaceutical Industry (London), publishes a Directory of Members, while the British and Overseas Pharmacist s Year Book (London, British and Colonial Druggist Ltd.) provides an alphabetical list of manufacturers and gives information on schools of pharmacy in many countries and institutions. The Chemist and Druggist Diary and Yearbook (Morgan) lists pharmaceutical suppliers, has a trade names index and also provides information on societies and institutions. The Pharmaceutical Society publishes annually an Index of New Products which gives the names and addresses of manufacturers with some technical information, while similar data with a list of trade names is given in the London Medical Handbook (British and Colonial Druggist Ltd.). Manufacturers are also listed alphabetically in the Proprietary Articles Trade Association Yearbook, and in the Retail Chemist Trade Price List of Proprietary Articles (London, Drury Press) which contains a list of trade names. British Chemical Plant (British Chemical Plant Manufacturers Association) lists its members. [Pg.46]

Trevor M. Jones The Association of the British Pharmaceutical Industry London, United Kingdom Jerome P. Skelly Alexandria, Virginia... [Pg.3]

Anon. Facts and Statistics for the Pharmaceutical Industry. London The Association of the British Pharmaceutical Industry, 2001. http // www.abpi.org.uk/statistics. [Pg.110]

In the United Kingdom, the information sheet provided to the consenting study subject in a clinical trial sponsored by a pharmaceutical company will usually contain a reference to the clinical trial compensation guidelines of the Association of the British Pharmaceutical Industry (ABPI). It is not included in the information sheet of noncommercial studies. Study subjects taking part in clinical trials are not usually paid, unless it is... [Pg.206]

There should be consistency between the possible adverse events described for the study drug in the protocol, investigator s brochure and ICF. Most coimtries have specific requirements for their ICF. It is essential that the requirements are known when the country-specific ICF is prepared. These examples could easily have changed by the time the reader is checking an ICF. In the United Kingdom, reference should be made to the ABPI (Association of the British Pharmaceutical Industry) Clinical Trial Compensation Guidelines. In other countries, for example, Ireland, the study subject is allowed a specific length of time to decide whether to enter the study. [Pg.245]

Association of the British Pharmaceutical Industry/ British Pharmaceutical Market Research Group. Guidelines on Pharmaceutical Market Research Practice. London ABPI, 1992. [Pg.379]

In the period intervening between its interim advice and its final report, the Joint Subcommittee received memoranda from, and met representatives of, the Association of the British Pharmaceutical Industry (ABPl), the BMA, the Pharmaceutical Society of Great Britain and the College of General Practitioners. [Pg.462]

In order to promote a uniform approach to offering compensation to subjects and indemnity to investigators and institutions conducting clinical trials, Medicines Australia has published a Form of Indemnity for Clinical Trials and Guidelines for Compensation for Injury Resulting from Participation in a Company-Sponsored Chnical Trial. These documents are based on those published by the Association of the British Pharmaceutical Industry and are available from www.medicinesaustralia.com.au (the Medicines Australia website). [Pg.679]

The prices of medicines sold to the NHS are controlled in the United Kingdom by the PPRS, negotiated periodically every 5 to 6 years by the DoH with the Association of the British Pharmaceutical Industry (ABPI), for example in 1979, 1986, 1993 and 1999. The PPRS controls the maximum - but not guaranteed - profits that pharmaceutical companies make on the capital they have invested in plant for research, development and manufacturing for sales made to the NHS. (Capital employed by the individual companies... [Pg.705]

ABPI. A Guide to the Pharmaceutical Price Regulation Scheme (PPRS). London Association of the British Pharmaceutical Industry, 1993. [Pg.718]

The Association of the British Pharmaceutical Industry (ABPI) is the trade association representing manufacturers of prescription medicines. It was formed in 1930 and now represents about eighty companies which supply nearly 80 per cent of the medicines used by the National Health Service. [Pg.730]

Paragraphs 10.4 and 12.2 of the Constitution and Procedure for the Prescription Medicines Code of Practice Authority authorize respectively the Code of Practice Appeal Board and the Board of Management of The Association of the British Pharmaceutical Industry to require an audit of a company s procedures in relation to the Code of Practice for the Pharmaceutical Industry to be carried out by the Prescription Medicines Code of Practice Authority. [Pg.783]

The Sponsor shall comply with all guidelines from time to time in force and published by the Association of the British Pharmaceutical Industry in relation to clinical trials and in particular those entitled Clinical Trial Compensation Guidelines (1991) a copy of which is set out in Appendix 3. [Pg.791]


See other pages where Association of British Pharmaceutical Industry is mentioned: [Pg.402]    [Pg.82]    [Pg.443]    [Pg.522]    [Pg.332]    [Pg.402]    [Pg.82]    [Pg.443]    [Pg.522]    [Pg.332]    [Pg.34]    [Pg.219]    [Pg.154]    [Pg.314]    [Pg.355]    [Pg.378]    [Pg.378]    [Pg.446]   
See also in sourсe #XX -- [ Pg.335 , Pg.420 , Pg.445 ]




SEARCH



Association of British Pharmaceutical

British industry

Industry associations

Pharmaceutical Association

Pharmaceutical Industry Association

Pharmaceutical industry

© 2024 chempedia.info